Psychedelic Data Society and Pneuma Gladius Announce Strategic Partnership to Advance the collection of Scientific data

Denver, CO – 06/01/2025 – The Psychedelic Data Society is proud to announce a groundbreaking partnership with Pneuma Gladius, a public benefit organization focused on advancing plant-based therapies for trauma, PTSD, and addiction. This collaboration aims to expand access to real-world data around the use of psychedelics in therapeutic settings and establish a scalable framework for evidence-based healing protocols.

At a time when global mental health systems are under strain and traditional treatments often fall short, psychedelic therapy is emerging as a promising alternative. Yet the field still lacks the volume and diversity of data required to develop universally recognized best practices. This partnership addresses that need head-on.

Through Pneuma Gladius’ growing network of healing centers and clinical facilitators—including their ongoing work with veterans and first responders—the collaboration will gather critical information on the variables that influence therapeutic outcomes. The Psychedelic Data Society’s open-source platform will securely house and analyze this anonymized data, making it accessible to researchers, practitioners, and institutions committed to responsible innovation in mental health care.

“Access to real-time, real-life data is essential if we are going to truly understand the healing potential of psychedelics,” said Kalin Harvey, Founder of the Psychedelic Data Society. “Our partnership with Pneuma Gladius creates a powerful bridge between lived experience and scientific insight.”

Todd Youngblood, Co-Founder of Pneuma Gladius, added, “Veterans and first responders deserve therapies that actually work. By participating in this data-sharing initiative, we’re not just helping individuals—we’re laying the groundwork for a mental health movement rooted in transparency, compassion, and measurable outcomes.”

Together, the two organizations are building a future where psychedelic therapies are not only more accessible but are also guided by science, shaped by real-world use, and grounded in community.

For more information about the partnership or to explore how to get involved, please visit:

www.psychedelicdata.io www.pneumagladius.org